These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 27665384)

  • 21. Long-term efficacy of standardised specific subcutaneous immunotherapy in children with persistent allergic rhinitis due to multiple allergens including house dust mites.
    Song Y; Long J; Wang T; Xie J; Wang M; Tan G
    J Laryngol Otol; 2018 Mar; 132(3):230-235. PubMed ID: 29374499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
    Devillier P; Wahn U; Zielen S; Heinrich J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.
    Demoly P; Emminger W; Rehm D; Backer V; Tommerup L; Kleine-Tebbe J
    J Allergy Clin Immunol; 2016 Feb; 137(2):444-451.e8. PubMed ID: 26292778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis.
    Wang ZX; Shi H
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):407-411. PubMed ID: 28585143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating allergic rhinitis by sublingual immunotherapy: a review.
    Incorvaia C; Di Rienzo A; Celani C; Makrì E; Frati F
    Ann Ist Super Sanita; 2012; 48(2):172-6. PubMed ID: 22751560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An observational, real-life safety study of a 5-grass pollen sublingual tablet in children and adolescents.
    Eberle P; Brueck H; Gall R; Hadler M; Sieber J; Karagiannis E
    Pediatr Allergy Immunol; 2014 Dec; 25(8):760-6. PubMed ID: 25378225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
    Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
    J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical considerations in the use of sublingual immunotherapy for allergic rhinitis.
    Lee S; Nolte H; Benninger MS
    Am J Rhinol Allergy; 2015; 29(2):106-14. PubMed ID: 25785750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Cost-Minimisation Analysis Comparing Sublingual Immunotherapy to Subcutaneous Immunotherapy for the Treatment of House Dust Mite Allergy in a Swedish Setting.
    Björstad Å; Cardell LO; Hahn-Pedersen J; Svärd M
    Clin Drug Investig; 2017 Jun; 37(6):541-549. PubMed ID: 28326466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel strategies for the treatment of grass pollen-induced allergic rhinitis.
    Larsson O; Hellkvist L; Peterson-Westin U; Cardell LO
    Expert Opin Biol Ther; 2016 Sep; 16(9):1143-50. PubMed ID: 27269991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.
    Đurić-Filipović I; Caminati M; Kostić G; Filipović Đ; Živković Z
    World J Pediatr; 2016 Aug; 12(3):283-290. PubMed ID: 27351563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence-based practice: sublingual immunotherapy for allergic rhinitis.
    Wise SK; Schlosser RJ
    Otolaryngol Clin North Am; 2012 Oct; 45(5):1045-54. PubMed ID: 22980684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.
    Passalacqua G; Canonica GW; Bagnasco D
    Curr Allergy Asthma Rep; 2016 Nov; 16(12):88. PubMed ID: 27957697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
    Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
    J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN; Cobanoglu N
    Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Developmental history of sublingual immunotherapy].
    Du W; Maekawa Y; Natsui K
    Nihon Yakurigaku Zasshi; 2019; 154(1):6-11. PubMed ID: 31308350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient selection for subcutaneous versus sublingual immunotherapy.
    Larenas-Linnemann D
    Curr Opin Allergy Clin Immunol; 2015 Dec; 15(6):588-95. PubMed ID: 26485098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.